Back to Search
RICHARD FURIE, M.D.
M.D.
Rheumatology Physician
NPI: 1538175740IndividualAccepts Medicare
Specialties, Licenses & Credentials
Rheumatology PhysicianPrimary
Internal Medicine — Rheumatology
Code: 207RR0500X
142505(NY)
CMS Specialties
PrimaryRHEUMATOLOGY
Education
JS WEILL MEDICAL COLLEGE, CORNELL UNIVERSITY
Class of 1979
Research & Publications (20)
Abetimus sodium (riquent) for the prevention of nephritic flares in patients with systemic lupus erythematosus.
PMID 16504827·Rheum Dis Clin North Am·2006
6-review
Dehydroepiandrosterone and biologics in the treatment of systemic lupus erythematosus.
PMID 11123039·Curr Rheumatol Rep·2000
6-review
Abetimus sodium: a medication for the prevention of lupus nephritis flares.
PMID 19505217·Expert Opin Pharmacother·2009
6-review
Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus.
PMID 18786258·Arthritis Res Ther·2008
3-trial
Abetimus sodium for renal flare in systemic lupus erythematosus: results of a randomized, controlled phase III trial.
PMID 18668592·Arthritis Rheum·2008
3-trial
Effects of prasterone on bone mineral density in women with active systemic lupus erythematosus receiving chronic glucocorticoid therapy.
PMID 18634158·J Rheumatol·2008
2-rct
Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti-tumor necrosis factor therapy.
PMID 18512710·Arthritis Rheum·2008
2-rct
Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks.
PMID 16947627·Arthritis Rheum·2006
3-trial
Analysis of single nucleotide polymorphisms in the promoter region of interleukin-10 by denaturing high-performance liquid chromatography.
PMID 16030322·J Biomol Tech·2005
4-observational
Peripheral blood gene expression profiling in rheumatoid arthritis.
PMID 15973463·Genes Immun·2005
8-other
Improvement in health-related quality of life in systemic lupus erythematosus patients enrolled in a randomized clinical trial comparing LJP 394 treatment with placebo.
PMID 14514130·Lupus·2003
3-trial
A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis.
PMID 12632425·Arthritis Rheum·2003
3-trial
LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: results from a randomized, double-blind, placebo-controlled study.
PMID 12571854·Arthritis Rheum·2003
3-trial
High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis.
PMID 12384917·Arthritis Rheum·2002
7-preclinical
The effect of anti-CD40 ligand antibody on B cells in human systemic lupus erythematosus.
PMID 12115186·Arthritis Rheum·2002
8-other
Pre-treatment affinity for LJP 394 influences pharmacodynamic response in lupus patients.
PMID 11530993·Lupus·2001
3-trial
Beta2-glycoprotein I-dependent anticardiolipin antibodies preferentially bind the amino terminal domain of beta2-glycoprotein I.
PMID 11522008·Thromb Haemost·2001
8-other
Clonal expansion is a characteristic feature of the B-cell repetoire of patients with rheumatoid arthritis.
PMID 11219389·Arthritis Res·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2800 MARCUS AVE
NEW HYDE PARK, NY 11042 - Phone
- (516) 708-2550
Quick Facts
- NPI
- 1538175740
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 47
- Publications
- 20
Are you this provider?
Claim Your Profile